These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20575024)

  • 101. Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome.
    Rossi D; Spina V; Cerri M; Rasi S; Deambrogi C; De Paoli L; Laurenti L; Maffei R; Forconi F; Bertoni F; Zucca E; Agostinelli C; Cabras A; Lucioni M; Martini M; Magni M; Deaglio S; Ladetto M; Nomdedeu JF; Besson C; Ramponi A; Canzonieri V; Paulli M; Marasca R; Larocca LM; Carbone A; Pileri SA; Gattei V; Gaidano G
    Clin Cancer Res; 2009 Jul; 15(13):4415-22. PubMed ID: 19509140
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.
    Chapiro E; Leporrier N; Radford-Weiss I; Bastard C; Mossafa H; Leroux D; Tigaud I; De Braekeleer M; Terré C; Brizard F; Callet-Bauchu E; Struski S; Veronese L; Fert-Ferrer S; Taviaux S; Lesty C; Davi F; Merle-Béral H; Bernard OA; Sutton L; Raynaud SD; Nguyen-Khac F
    Leuk Res; 2010 Jan; 34(1):63-8. PubMed ID: 19406473
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The prognostic value of TP53 mutations in chronic lymphocytic leukemia is independent of Del17p13: implications for overall survival and chemorefractoriness.
    Rossi D; Cerri M; Deambrogi C; Sozzi E; Cresta S; Rasi S; De Paoli L; Spina V; Gattei V; Capello D; Forconi F; Lauria F; Gaidano G
    Clin Cancer Res; 2009 Feb; 15(3):995-1004. PubMed ID: 19188171
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion.
    Forconi F; Rinaldi A; Kwee I; Sozzi E; Raspadori D; Rancoita PM; Scandurra M; Rossi D; Deambrogi C; Capello D; Zucca E; Marconi D; Bomben R; Gattei V; Lauria F; Gaidano G; Bertoni F
    Br J Haematol; 2008 Nov; 143(4):532-6. PubMed ID: 18752589
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.
    Gattei V; Bulian P; Del Principe MI; Zucchetto A; Maurillo L; Buccisano F; Bomben R; Dal-Bo M; Luciano F; Rossi FM; Degan M; Amadori S; Del Poeta G
    Blood; 2008 Jan; 111(2):865-73. PubMed ID: 17959854
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping.
    Haferlach C; Dicker F; Schnittger S; Kern W; Haferlach T
    Leukemia; 2007 Dec; 21(12):2442-51. PubMed ID: 17805327
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.
    Pfeifer D; Pantic M; Skatulla I; Rawluk J; Kreutz C; Martens UM; Fisch P; Timmer J; Veelken H
    Blood; 2007 Feb; 109(3):1202-10. PubMed ID: 17053054
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.
    Schwaenen C; Nessling M; Wessendorf S; Salvi T; Wrobel G; Radlwimmer B; Kestler HA; Haslinger C; Stilgenbauer S; Döhner H; Bentz M; Lichter P
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):1039-44. PubMed ID: 14730057
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 110. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.
    Cheson BD; Bennett JM; Grever M; Kay N; Keating MJ; O'Brien S; Rai KR
    Blood; 1996 Jun; 87(12):4990-7. PubMed ID: 8652811
    [No Abstract]   [Full Text] [Related]  

  • 111. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 112. MYCN oncoprotein targets and their therapeutic potential.
    Bell E; Chen L; Liu T; Marshall GM; Lunec J; Tweddle DA
    Cancer Lett; 2010 Jul; 293(2):144-57. PubMed ID: 20153925
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Genes and chromosomes in chronic B-cell leukemia.
    Crossen PE
    Cancer Genet Cytogenet; 1997 Mar; 94(1):44-51. PubMed ID: 9078290
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Regulation of the turnover of mRNAs encoding cellular oncoproteins.
    Saini KS; Summerhayes IC
    Biochem Cell Biol; 1991 Jul; 69(7):415-7. PubMed ID: 1838927
    [No Abstract]   [Full Text] [Related]  

  • 115. Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia.
    Deambrogi C; De Paoli L; Fangazio M; Cresta S; Rasi S; Spina V; Gattei V; Gaidano G; Rossi D
    Am J Hematol; 2010 Jul; 85(7):541-4. PubMed ID: 20575024
    [No Abstract]   [Full Text] [Related]  

  • 116. Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.
    Migliazza A; Cayanis E; Bosch-Albareda F; Komatsu H; Martinotti S; Toniato E; Kalachikov S; Bonaldo MF; Jelene P; Ye X; Rzhetsky A; Qu X; Chien M; Inghirami G; Gaidano G; Vitolo U; Saglio G; Resegotti L; Zhang P; Soares MB; Russo J; Fischer SG; Edelman IS; Efstratiadis A; Dalla-Favera R
    Curr Top Microbiol Immunol; 2000; 252():275-84. PubMed ID: 11125485
    [No Abstract]   [Full Text] [Related]  

  • 117. The MYCN oncoprotein as a drug development target.
    Lu X; Pearson A; Lunec J
    Cancer Lett; 2003 Jul; 197(1-2):125-30. PubMed ID: 12880971
    [TBL] [Abstract][Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.